Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/ transforming growth factor-β (TGF-β1)/Smad axis

References

• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549–574. PubMed PMID: 23649149; PubMed Central PMCID: PMCPMC3769482
   PubMed Web of Science ®Google Scholar
• Piek A, de Boer RA, Sillje HH. The fibrosis-cell death axis in heart failure. Heart Fail Rev. 2016;21(2):199–211. PubMed PMID: 26883434; PubMed Central PMCID: PMCPMC4762920
   PubMed Web of Science ®Google Scholar
• Alex L, Russo I, Holoborodko V, et al. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018;315(4):H934–H49. PubMed PMID: 30004258; PubMed Central PMCID: PMCPMC6230908
   PubMed Web of Science ®Google Scholar
• Arcari L, Hinojar R, Engel J, et al. Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions - Comparison of uremic, hypertensive and hypertrophic cardiomyopathy. Int J Cardiol. 2020;306:102–108. PubMed PMID: 32169347
   PubMed Web of Science ®Google Scholar
• Darakhshan S, Pour AB. Tranilast: a review of its therapeutic applications. Pharmacol Res. 2015;91:15–28. PubMed PMID: 25447595
   PubMed Web of Science ®Google Scholar
• Kato M, Takahashi F, Sato T, et al. Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta/SMAD2 pathway. Drug Des Devel Ther. 2020;14:4593–4603. PubMed PMID: 33149556; PubMed Central PMCID: PMCPMC7605600
   PubMed Web of Science ®Google Scholar
• Zhuo Y, Zhuo J. Tranilast treatment attenuates cerebral ischemia-reperfusion injury in rats through the inhibition of inflammatory responses mediated by NF-kappaB and PPARs. Clin Transl Sci. 2019;12(2):196–202. PubMed PMID: 30548101; PubMed Central PMCID: PMCPMC6440572
   PubMed Web of Science ®Google Scholar
• Zhuang T, Li S, Yi X, et al. Tranilast directly targets NLRP3 to protect melanocytes from keratinocyte-derived IL-1beta under oxidative stress. Front Cell Dev Biol. 2020;8:588. PubMed PMID: 32754591; PubMed Central PMCID: PMCPMC7365842
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Shang X. Effect of tranilast on myocardial fibrosis in diabetes rats through TGF-beta/Smad pathway. Minerva Med. 2021;112(1):153–154. PubMed PMID: 31295986
   PubMed Web of Science ®Google Scholar
• See F, Watanabe M, Kompa AR, et al. Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarction. Heart Lung Circ. 2013;22(2):122–132. PubMed PMID: 22986349
   PubMed Web of Science ®Google Scholar
• Kagitani S, Ueno H, Hirade S, et al. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats. J Hypertens. 2004;22(5):1007–1015. PubMed PMID: 15097242
   PubMed Web of Science ®Google Scholar
• Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med. 2007;7(8):711–724. PubMed PMID: 18331229
   PubMed Web of Science ®Google Scholar
• He H, Li J, Weng S, et al. S100A11: diverse function and pathology corresponding to different target proteins. Cell Biochem Biophys. 2009;55(3):117–126. PubMed PMID: 19649745
   PubMed Web of Science ®Google Scholar
• Martinez-Martinez E, Ibarrola J, Lachen-Montes M, et al. Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts. J Proteomics. 2017;166:93–100. PubMed PMID: 28739510
   PubMed Web of Science ®Google Scholar
• Sobolewski C, Abegg D, Berthou F, et al. S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut. 2020;69(10):1841–1854. PubMed PMID: 31919231
   PubMed Web of Science ®Google Scholar
• Huang YK, Chou RH, Yu C. Tranilast blocks the interaction between the protein S100A11 and receptor for advanced glycation end products (RAGE) V domain and inhibits cell proliferation. J Biol Chem. 2016;291(27):14300–14310. PubMed PMID: 27226584; PubMed Central PMCID: PMCPMC4933184
   PubMed Web of Science ®Google Scholar
• Gao F, Wu H, Wang R, et al. MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2. Bioengineered. 2019;10(1):1–12. PubMed PMID: 30836864; PubMed Central PMCID: PMCPMC6527069
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang ZY, Du H, et al. DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer. Cell Death Differ. 2019;26(11):2300–2313. PubMed PMID: 30778200; PubMed Central PMCID: PMCPMC6889501
   PubMed Web of Science ®Google Scholar
• Wang S, Gong H, Jiang G, et al. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent beta-arrestin2 pathways. PLoS One. 2014;9(4):e92926. PubMed PMID: 24699426; PubMed Central PMCID: PMCPMC3974699
   PubMed Web of Science ®Google Scholar
• Sun Y. Local angiotensin II and myocardial fibrosis. Adv Exp Med Biol. 1997;432:55–61. PubMed PMID: 9433511
   PubMed Web of Science ®Google Scholar
• Qiao W, Wang C, Chen B, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology. 2015;131(2):97–106. PubMed PMID: 25896805
   PubMed Web of Science ®Google Scholar
• Huang L, Dong Y, Wu J, et al. Sinomenine-induced histamine release-like anaphylactoid reactions are blocked by tranilast via inhibiting NF-kappaB signaling. Pharmacol Res. 2017;125(PtB):150–160. PubMed PMID: 28867637
   PubMedGoogle Scholar
• Yin DD, Luo JH, Zhao ZY, et al. Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease. Mol Med Rep. 2018;17(5):7356–7364. PubMed PMID: 29568954
   PubMed Web of Science ®Google Scholar
• Said E, Said SA, Elkashef WF, et al. Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice. Inflammopharmacology. 2012;20(2):77–87. PubMed PMID: 22278738
   PubMedGoogle Scholar
• Kim DH, Beckett JD, Nagpal V, et al. Calpain 9 as a therapeutic target in TGFbeta-induced mesenchymal transition and fibrosis. Sci Transl Med. 2019;11(501):eaau2814. PubMed PMID: 31316008; PubMed Central PMCID: PMCPMC7351287
   Web of Science ®Google Scholar
• Shinde AV, Humeres C, Frangogiannis NG. The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis. 2017;1863(1):298–309. PubMed PMID: 27825850; PubMed Central PMCID: PMCPMC5163362
   PubMed Web of Science ®Google Scholar
• Sugiyama A, Hirano Y, Okada M, et al. Endostatin stimulates proliferation and migration of myofibroblasts isolated from myocardial infarction model rats. Int J Mol Sci. 2018;19(3):741. PubMed PMID: 29509663; PubMed Central PMCID: PMCPMC5877602
   Web of Science ®Google Scholar
• Huang DD, Huang HF, Yang Q, et al. Liraglutide improves myocardial fibrosis after myocardial infarction through inhibition of CTGF by activating cAMP in mice. Eur Rev Med Pharmacol Sci. 2018;22(14):4648–4656. PubMed PMID: 30058704
   PubMed Web of Science ®Google Scholar
• Zhang M, Zheng S, Jing C, et al. S100A11 promotes TGF-beta1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma. Future Oncol. 2018;14(9):837–847. PubMed PMID: 29569474
   PubMed Web of Science ®Google Scholar
• Niu Y, Shao Z, Wang H, et al. LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFbeta/Smad signaling. Sci Rep. 2016;6(1):26112. PubMed PMID: 27181092; PubMed Central PMCID: PMCPMC4867635
   PubMedGoogle Scholar
• Tarbit E, Singh I, Peart JN, et al. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells. Heart Fail Rev. 2019;24(1):1–15. PubMed PMID: 29987445
   PubMed Web of Science ®Google Scholar